Therapy-related leukemia following chemoradiotherapy for esophageal cancer

European Journal of Haematology

Volumn 85, Issue 4, 2010, Pages 353-357

  Mimura, Naoya ^a   Tsujimura, Hideki ^a   Ise, Mikiko ^a   Sakai, Chikara ^a   Takagi, Toshiyuki ^a   Nagata, Matsuo ^a   Kumagai, Kyoya ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

balanced chromosomal abnormalities; chemoradiotherapy; esophageal cancer; therapy related leukemia

Indexed keywords

ACLARUBICIN; CYTARABINE; CYTARABINE 5' STEARYLPHOSPHATE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMATINIB; MITOXANTRONE; NEDAPLATIN; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANAMNESIS; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME DELETION; DRUG MEGADOSE; DRUG WITHDRAWAL; ESOPHAGUS CANCER; HUMAN; KARYOTYPE; LEUKEMIA; LEUKOCYTOSIS; MALE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; RASH; REFRACTORY ANEMIA; TREATMENT OUTCOME; CHEMICALLY INDUCED; ESOPHAGEAL NEOPLASMS; FEMALE; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYELODYSPLASTIC SYNDROMES; PATHOLOGY; SECOND CANCER;

AGED; ANTINEOPLASTIC AGENTS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 5; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY;

EID: 77956975407     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01487.x     Document Type: Article

References (29)

1. Siersema PD. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer. Curr Opin Gastroenterol 2007 23 : 456 461.
2. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007 25 : 4110 4117.
3. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999 281 : 1623 1627.
4. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001 19 : 305 313.
5. Kodaira T, Fuwa N, Kamata M, et al. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma. Anticancer Res 2006 26 : 471 478.
6. Sato Y, Takayama T, Sagawa T, et al. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer. Cancer Chemother Pharmacol 2006 58 : 570 576.
7. Yamashita H, Nakagawa K, Tago M, et al. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study. Dis Esophagus 2006 19 : 15 9.
8. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003 21 : 2697 2702. (Pubitemid 46606313)
9. Kumekawa Y, Kaneko K, Ito H, et al. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 2006 41 : 425 432.
10. Nagata M, Yamamoto H, Takiguchi N, et al. Neoadjuvant chemotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell cartinoma. Esophagus 2006 3 : 105 111.
11. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002 100 : 2292 2302.
12. Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia 1995 9 : 10 4.
13. Leone G, Pagano L, Ben-Yehuda D, Voso MT. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007 92 : 1389 1398.
14. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008 22 : 240 248.
15. Travis LB, Holowaty EJ, Bergfeldt K, et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med 1999 340 : 351 357.
16. Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003 102 : 43 52.
17. Brusamolino E, Anselmo AP, Klersy C, et al. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Haematologica 1998 83 : 812 823.
18. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002 100 : 1989 1996.
19. Franklin J, Pluetschow A, Paus M, et al. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol 2006 17 : 1749 1760.
20. Pedersen-Bjergaard J, Andersen MK, Christiansen DH. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 2000 95 : 3273 3279.
21. Hake CR, Graubert TA, Fenske TS. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients? Bone Marrow Transplant 2007 39 : 59 70.
22. Linassier C, Barin C, Calais G, et al. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol 2000 11 : 1289 1294.
23. Howard RA, Gilbert ES, Chen BE, et al. Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res Treat 2007 105 : 359 368.
24. Chaudhary UB, Haldas JR. Long-term complications of chemotherapy for germ cell tumours. Drugs 2003 63 : 1565 1577.
25. Andersen MK, Johansson B, Larsen SO, Pedersen-Bjergaard J. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica 1998 83 : 483 488.
26. Block AW, Carroll AJ, Hagemeijer A, et al. Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002 33 : 401 412.
27. Bauduer F, Ducout L, Dastugue N, Marolleau JP. Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: a report of three cases and a brief review of the literature. Leuk Lymphoma 2002 43 : 1057 1060.
28. Andersen MK, Christiansen DH, Jensen BA, et al. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001 114 : 539 543.
29. Bloomfield CD, Archer KJ, Mrozek K, et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002 33 : 362 378. (Pubitemid 34208798)